Two Companies Recall Dietary Supplements Containing Poisonous Plant

ICARO Media Group
News
25/02/2024 17h15

Two companies have issued recalls for their dietary supplements after the U.S. Food and Drug Administration (FDA) testing revealed the presence of a poisonous plant. Backstage Center is recalling around 280 bottles of Alipotec Raiz de Tejocote labeled with the "Alipotec King" sticker, sold on Amazon.com since September 15, 2023. The FDA discovered that the products actually contain toxic yellow oleander instead of tejocote, posing serious health risks to consumers.

Consumption of the contaminated supplements may lead to various adverse effects, such as neurological, gastrointestinal, and cardiovascular issues. Symptoms can range from nausea, vomiting, dizziness, and diarrhea to abdominal pain, cardiac dysrhythmia, and more. While no illnesses or injuries related to the product have been reported to date, customers are urged to discontinue use immediately and follow instructions on the company's website for returning the recalled product.

Additionally, G.A. Mart dba H&Natural is also recalling specific lots of H&NATURAL TejoRoot and H&NATURAL Brazil Seed after FDA testing revealed the presence of yellow oleander. The products were distributed through handnatural.com, Amazon.com, and Walmart.com. One report of a customer experiencing gastrointestinal illness and internal bleeding linked to H&NATURAL TejoRoot has been received by the company.

Customers who have purchased the recalled products are advised to stop using them and seek a refund by contacting the respective companies. Individuals who have encountered health issues possibly related to the supplements should consult their healthcare provider. The FDA previously warned consumers in January about certain dietary supplements falsely labeled as tejocote root or Brazil seed, which were found to contain yellow oleander. The FDA is collaborating with third-party platforms and further testing is ongoing to address the issue promptly.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related